US private equity deal value climbed roughly 8% year over year in the first half of 2025, reaching just over $195 billion as dry powder dropped from a December 2024 peak of $1.3 trillion to around $880 billion by September, per PwC’s 2026 private equity outlook. For JP Conte, Managing Partner of Lupine Crest Capital, that concentration of activity into fewer, larger transactions is the most significant feature of the current deal market — and the clearest argument for patient capital.
PwC counted 47 megadeals valued at $5 billion or more through the first nine months of 2025, putting the year on pace to finish 31% above 2024’s megadeal count. Industrial manufacturing saw transactions above $5 billion account for 52% of total deal value in 2025, up from just 18% the year prior. At the top of the market, bid sheets are crowded and the buyer pool has narrowed to a handful of well-capitalized platforms. Large diversified asset managers are taking a growing share of total LP commitments, with limited partners backing fewer firms and demanding more demonstrated discipline from the ones they back.
That concentration is reshaping what’s available in the middle market. Mid-sized sponsors losing megadeal targets are moving down the size curve, intensifying competition in the next tier of assets. Family offices like JP Conte’s Lupine Crest Capital can move faster on operating asset due diligence without committee approval — an advantage that becomes more visible as deal timelines tighten. Lupine Crest operates across private equity, real estate, and venture, with a middle-market focus on healthcare, financial services, software, and industrial technology.
The structural case for Lupine Crest Capital has sharpened with the pricing environment. Family offices carrying permanent capital hold through dislocation rather than around it, which means the same asset is worth more to them than to a fund-stage sponsor pricing in a forced exit by year five. Sponsor-led deals run on 60-to-90-day timelines set by lenders and exit schedules — constraints that Conte’s structure doesn’t carry. The J-P Conte Family Foundation, established in 2017, extends that same long-range perspective into his philanthropic work.